All three missense KRAS mutations occurred at known hotspots of amino acid residues of position 12, 13 and 61 (G12D, G13D, Q61L in ICC26, ICC6, ICC41, respectively) as likely cancer drivers of three ICC cases. This evidence concerns the gene KRAS and intrahepatic cholangiocarcinoma.